The insertion of cryopreserved homograft conduit into the pulmonary outflow tract is an effective method of relieving severe pulmonary valve dysfunction. A certain proportion of the inserted homografts undergo late degeneration resulting in progressive right ventricular outflow obstruction. When severe, this obstruction needs repeat intervention. The timing of this intervention is critical and depends on a thorough assessment of symptoms, coupled with detailed evaluation of right ventricular structure and function as well as flow dynamics in the right ventricular outflow. We report a patient who illustrates many of the issues related to management of these patients with particular reference to the use of modern imaging followed by detailed image processing.
INTRODUCTION
The insertion of cryopreserved homograft conduit into the pulmonary outflow tract is an effective method of relieving severe pulmonary valve dysfunction. A certain proportion of the inserted homografts undergo late degeneration resulting in progressive right ventricular outflow obstruction. When severe, this obstruction needs repeat intervention. The timing of this intervention is critical and depends on a thorough assessment of symptoms, coupled with detailed evaluation of right ventricular structure and function as well as flow dynamics in the right ventricular outflow. We report a patient who illustrates many of the issues related to management of these patients with particular reference to the use of modern imaging followed by detailed image processing.
CLINICAL HISTORY
A 16-year-old young man underwent open pulmonary valvotomy and insertion of transannular pericardial patch by Dr. Debakey in March 1968. He remained in good health until 2002, when he started feeling short of breath. Investigations revealed severe pulmonary regurgitation with marked dilatation of the pulmonary outflow and main pulmonary artery (MPA). The latter measured 6 cm in diameter.
In May 2004, at the age of 52 years, he underwent pulmonary valve replacement using an aortic homograft measuring 2.4 cm in diameter. This was the only homograft available at the time. Post-operatively, he made a smooth recovery and has been followed up at yearly intervals since. He remained asymptomatic, however, routine echocardiography six months after the operation showed a peak gradient of 25mmHg across the right ventricular outflow with evidence of diminution of right ventricular size and a competent pulmonary valve (homograft). The peak systolic gradient across the pulmonary outflow remained stable at 36mmHg.
The question of reoperation was raised by the patient and his referring physician. To help decide about the need and timing of such a re-intervention, the following investigations were performed in order to determine structure and flow dynamics in the right ventricle, the ventricular outflow tract and the pulmonary artery.
STRUCTURAL CHANGES
Gadolinium-enhanced magnetic resonance (MR) images were acquired using a 1.5 Tesla clinical scanner (Siemens Symphony) with a slice increment of 2.5 mm and slice thickness of 2.5 mm. Images stored in DICOM format were imported into a commercial medical image processing tool The 3D model showed slightly enlarged right ventricular (RV) cavity with good contractility. Importantly there was no evidence of RV hypertrophy, with the thickness of the free wall of the RV measuring 2 mm. The allograft valve (shown in dark grey in Figure 1 ) measured 2.4 cm in diameter, which was identical to the original size at insertion. The main and left pulmonary arteries were markedly dilated, measuring 4.19 cm and 4.35 cm respectively (Figure 1 ).
FLOW DYNAMICS
In-plane as well as through-plane, cine phase-contract MR images were acquired over the cardiac cycle in order to assess spatio-temporal flow characteristics. The in-plane images (Figure 2) , encoding blood flow velocity in head-foot direction, were acquired in sagittal-oblique plane to depict the long-axis of the main pulmonary trunk with slice thickness 5 mm and encoding velocity (V enc ) 3.5 m/s. The through-plane images were acquired immediately downstream to the pulmonary valve with same slice thickness and encoding velocity. The velocity map in Figure 2 illustrates a systolic jet through the homograft and regurgitation in diastole. The peak jet velocity was confirmed to be 2.87 m/s by the through-plane velocity map (Figure 3 ), equating to 33 mmHg of transvalvular pressure gradient. The regurgitant velocity was 2 0.49 m/s. The cardiac output measured 4.55 L/min. Applying the jet shear layer detection method by Garcia et al. 1 to the through-plane velocity map, effective orifice area (EOA) was also estimated to be 1.36 cm 2 . Investigating pressure recovery, energy loss (E L ) and indexed energy loss coefficient (E LCi ) were also calculated as 26.7 mmHg and 0.89 cm 2 /m 2 following the equations below.
Here, v o is the systolic peak velocity at the orifice and A MPA is the cross-sectional area of the main pulmonary trunk that was calculated from the diameter. Energy loss is in mmHg and was initially introduced to indicate the portion of the transvalvular pressure that is not recovered, in order to assess the severity of aortic stenosis. Indexed energy loss coefficient is an improved indicator which has been shown better correlated to clinical outcomes, i.e. mortality and reoperation. 3 -6 We refer to both parameters, former for the direct indication of the ventricular afterload and the latter as more clinically-relevant score.
The diameter of the homograft in proportion to the dilated MPA was 57% and also due to relatively small orifice area equivalent to a moderate stenosis in case of the aorta (Bonow et al. 3 ), the flow through the homograft became a high-speed jet. The jet flowing into the dilated MPA is accompanied by flow separation and recirculation (Figure 3 ) which are likely cause of disturbance in the flow, resulting in a significant energy loss that was estimated 26.6 mmHg. This means that the RV of this patient is required to provide extra 26.6 mmHg of pressure to overcome energy loss and ensure perfusion of the blood to the lungs. 
